JENCINE 4+L5

  • Overview

Therapeutic Class

Jencine® 4+L5


Pharmaceutical Name
Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza3, Respiratory Syncytial Virus Vaccine, Leptospira Canicola-Grippotyphosa-Hardjo- Icterohaemorrhagiae-Pomona Bacterin 



Features and Benefits

… protection you need with convenience you want.

For vaccination of healthy cattle as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD) types 1 and 2, bovine parainfluenza3 (PI3), and bovine respiratory syncytial virus (BRSV) and for protection against clinical disease caused by L. canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona. Vaccination of dams prior to breeding aids in the prevention of persistently infected calves due to BVD type 1.

  • Protects against Leptospira serovars recognized for potential to cause setbacks and losses and proven in studies.*

  • And combines all of the advantages of Jencine 4 vaccine.

  • A true single-dose product to reduce labor, animal stress, and cost of processing.

  • Given subcutaneous to comply with BQA guidelines and reduce injection site blemishes.

* Data on file at Schering-Plough Animal Health Corp. 
 
Dosage
For further information including dose rate and complete directions and warnings, please see the Product Label by clicking here.
 
Jencine® 4+L5 is a registered trademark of Schering-Plough Animal Health Corporation.